logo

CNTX

Context TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

CNTX Profile

Context Therapeutics Inc.

A biopharmaceutical company focused on developing hormone therapies for cancer treatment

Pharmaceutical
--
10/20/2021
NASDAQ Stock Exchange
12
12-31
Common stock
2001 Market Street, Suite 3915, Unit #15, Philadelphia, Pennsylvania 19103
--
Context Therapeutics Inc., was incorporated in Delaware in April 2015. It is a clinical-stage biopharmaceutical company dedicated to improving the lives of women suffering from cancer. Far-reaching advances in oncology drug development have expanded the treatment options available to women with cancer, but treatment resistance and recurrence continue to limit the efficacy and duration of such treatments.